Connection

Crystal Zheng to Melanoma

This is a "connection" page, showing publications Crystal Zheng has written about Melanoma.
Connection Strength

1.114
  1. Melanoma risk during immunomodulating treatment. Melanoma Res. 2022 12 01; 32(6):411-418.
    View in: PubMed
    Score: 0.462
  2. Poor melanoma outcomes and survival in Asian American and Pacific Islander patients. J Am Acad Dermatol. 2021 Jun; 84(6):1725-1727.
    View in: PubMed
    Score: 0.402
  3. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma. Mol Cancer. 2024 02 22; 23(1):40.
    View in: PubMed
    Score: 0.128
  4. Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment. Oncotarget. 2023 05 26; 14:543-560.
    View in: PubMed
    Score: 0.122
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.